Question 1

What specific benefits do you think KBL697 might offer me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis clinical trial (NCT04911751). Contact the study team or your healthcare provider for specific answers.

Question 2

How does KBL697 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis clinical trial (NCT04911751). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with KBL697?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis clinical trial (NCT04911751). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis clinical trial (NCT04911751). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis clinical trial (NCT04911751). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis clinical trial (NCT04911751). Contact the study team or your healthcare provider for specific answers.

What this study is about